发布: 2018年05月05日第8卷第9期 DOI: 10.21769/BioProtoc.2842 浏览次数: 23344
评审: Renate WeizbauerRainer MelzerPeter E Burby
Abstract
This protocol provides step by step instructions (Figure 1) for heterologous expression of Francisella novicida Cas12a (previously known as Cpf1) in Escherichia coli. It additionally includes a protocol for high-purity purification and briefly describes how activity assays can be performed. These protocols can also be used for purification of other Cas12a homologs and the purified proteins can be used for subsequent genome editing experiments. 
Figure 1. Timeline of activities for the heterologous expression and purification of Francisella novicida Cas12a (FnCas12a) from Escherichia coli
Background
Prokaryotic CRISPR-Cas immune systems provide protection against viruses and plasmids by using CRISPR RNAs (crRNAs) as a guide for sequence-specific targeting of foreign DNA or RNA (van der Oost et al., 2014; Marraffini, 2015). Class 1 CRISPR-Cas systems (comprising types I, III, and IV) typically form multi-subunit protein-crRNA effector complexes, while the class 2 systems (comprising types II, V, and VI) rely on single crRNA-guided effector nucleases for target interference (Mohanraju et al., 2016).
Effector nuclease enzymes from the Class 2 CRISPR-Cas systems have emerged as efficient and precise tools for genome editing and gene expression control (Mali et al., 2013; Doudna and Charpentier, 2014; Hsu et al., 2014). The widely used Cas9, which is the signature protein of type II systems, utilizes a dual guide RNA structure consisting of crRNA and a trans-activating crRNA (tracrRNA) for target recognition (Deltcheva et al., 2011). For genome editing purposes, the dual guide RNA is often replaced by a synthetic fusion of the mature crRNA and tracrRNA, resulting in a long single-molecule guide RNA (sgRNA) in which the individual RNAs are fused by a short linker sequence (Jinek et al., 2012). The sequence of the guide RNA allows binding of complementary DNA targets by base pairing with the target strand, while the other strand of the DNA is displaced. Upon finding a cognate DNA target, the HNH and RuvC nuclease domains of Cas9 mediate cleavage of the target and the displaced strand, respectively (Jinek et al., 2012; Karvelis et al., 2013).
More recently, another novel class 2 CRISPR-Cas nuclease with distinctive features has been identified in bacterial genomes: Cas12a (also known as Cpf1) (Makarova and Koonin, 2015; Zetsche et al., 2015; Shmakov et al., 2017). Cas12a utilizes a single crRNA guide for DNA targeting; it does not require a tracrRNA, resulting in a shorter gRNA sequence compared to the chimeric single-molecule guide RNAs (sgRNA) used by Cas9. While Cas9 requires RNase III-mediated processing of pre-crRNA or individual expression of sgRNAs for the formation of mature guide RNAs, Cas12a can process its own pre-crRNA. This pre-crRNA processing activity allows for simple multiplexing in Cas12a-mediated genome editing (Wang et al., 2017; Zetsche et al., 2017). Whereas Cas9 generates double stranded DNA breaks (DSBs) that are blunt ended, Cas12a generates staggered-end DSBs (Zetsche et al., 2015). Such overhangs can be utilized for overhang-based cloning (Li et al., 2016; Lei et al., 2017). Moreover, Cas9 typically recognizes a G-rich PAM sequence, while all Cas12a orthologues characterized to date recognize a T-rich PAM sequence (Zetsche et al., 2015). Taken together, these features make Cas12a a valuable addition to the genome editing toolbox.
Cas12a has been successfully repurposed for genome editing applications in mammalian cells (Zetsche et al., 2015; Kim et al., 2016a), mice (Hur et al., 2016; Kim et al., 2016b), rice (Endo et al., 2016; Hu et al., 2017; Xu et al., 2017), yeast (Verwaal et al., 2017; Swiat et al., 2017), zebrafish, xenopus (Moreno-Mateos et al., 2017), microalga (Ferenczi et al., 2017) and plant cells (Zaidi et al., 2017; Kim et al., 2017; Tang et al., 2017). The high efficiency and specificity of Cas12a in human cells, coupled with fewer off-target cleavage events compared to Cas9 (Kleinstiver et al., 2016), makes Cas12a a robust and reliable tool for genome editing.
For its in vitro characterization and crystallization (Swarts et al., 2017), Cas12a from Francisella novicida U112 was purified after heterologous expression in Escherichia coli. The expression strain E. coli RosettaTM 2 (DE3) carries a chromosomal T7 RNA polymerase gene under control of an IPTG inducible lacUV5 promoter. The cas12a gene is expressed using a pET vector (Studier and Moffatt, 1986; Rosenberg et al., 1987; Studier et al., 1990) with a lacI-controlled T7 promoter. Here we describe the steps required for controlled expression and purification of FnCas12a. The protocol can also be used for the expression and purification of Cas12a homologs from Acidaminococcus sp. and Lachnospiraceae bacterium.
Materials and Reagents
Note: Equivalent materials and reagents may be used as substitutes.

Equipment
Note: Equivalent equipment can be used.
Procedure
登录 / 注册后阅读全文
文章信息
版权信息
© 2018 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Mohanraju, P., Oost, J. V. D., Jinek, M. and Swarts, D. C. (2018). Heterologous Expression and Purification of the CRISPR-Cas12a/Cpf1 Protein. Bio-protocol 8(9): e2842. DOI: 10.21769/BioProtoc.2842.
分类
微生物学 > 异源表达系统 > 大肠杆菌
微生物学 > 微生物生物化学 > 蛋白质 > 活性
生物化学 > 蛋白质 > 分离和纯化
您对这篇实验方案有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
Share
Bluesky
X
Copy link




